Skip to main content
logo
Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.960
-0.300 (-5.70%)
At close: May 15, 2026, 4:00 PM EDT
4.975
+0.015 (0.30%)
After-hours: May 15, 2026, 6:02 PM EDT

Coya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1161219610712-
Market Cap Growth
10.77%26.83%-10.31%769.77%--
Enterprise Value
65.6274.657.3974.1228.10
Last Close Price
4.965.805.737.414.74-
PE Ratio
--4.57-5.85-9.38-1.00-
PS Ratio
14.6615.2826.9417.78--
PB Ratio
2.382.822.423.00-1.46-
P/TBV Ratio
1.852.262.212.11-1.46-
P/FCF Ratio
--11.31-9.30-9.54-1.70-
P/OCF Ratio
--11.31-9.30-9.54-1.70-
EV/Sales Ratio
8.279.3916.1512.35--
EV/EBITDA Ratio
--3.31-3.33-9.41-2.87-
EV/EBIT Ratio
--3.31-3.33-9.38-2.86-
EV/FCF Ratio
--6.95-5.58-6.62-3.88-
Debt / Equity Ratio
-000-1.540
Debt / EBITDA Ratio
-----1.32-
Debt / FCF Ratio
-----1.79-
Net Debt / Equity Ratio
-1.04-1.09-0.97-0.92-0.84-1.19
Net Debt / EBITDA Ratio
2.262.082.234.14-0.720.89
Net Debt / FCF Ratio
3.594.363.732.92-0.971.07
Asset Turnover
0.150.170.080.2400
Quick Ratio
14.307.9710.027.941.553.78
Current Ratio
15.028.5011.598.151.883.99
Return on Equity (ROE)
-45.93%-51.39%-39.57%-58.64%515.59%-268.50%
Return on Assets (ROA)
-43.63%-47.85%-38.44%-35.00%-148.81%-203.26%
Return on Invested Capital (ROIC)
3453.69%-3039.23%-436.56%-552.70%953.44%1398.61%
Return on Capital Employed (ROCE)
-48.01%-53.32%-44.96%-38.76%-238.86%-267.33%
Earnings Yield
-18.16%-21.90%-17.10%-10.66%-99.83%-
FCF Yield
-12.14%-8.84%-10.75%-10.48%-58.99%-
Buyback Yield / Dilution
-15.23%-9.79%-49.93%-292.40%-0.01%-0.00%
Total Shareholder Return
-15.23%-9.79%-49.93%-292.40%-0.01%-0.00%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q